Cabot Corporation Announces Election of Thierry Vanlancker to Board of Directors
Cabot Corporation Announces Election of Thierry Vanlancker to Board of Directors
BOSTON--(BUSINESS WIRE)--Jul. 12, 2024--Cabot Corporation (NYSE: CBT) announced today that Thierry Vanlancker has been elected to its Board of Directors, effective July 12, 2024. He was also appointed a member of the Audit Committee of the Board of Directors, effective July 12, 2024. Prior to his retirement, Mr. Vanlancker was Chief Executive Officer and a Director of AkzoNobel NV, a multinational paints and coatings company, from 2017 to 2022. Prior to joining AkzoNobel, Mr. Vanlancker was President of Fluoroproducts and the EMEA region at The Chemours Company, a global provider of performance chemicals, from 2015 to 2016, and from 1988 to 2015 held various positions within the chemicals company Dupont. Mr. Vanlancker has been a member of the Board of Directors of SIKA AG, a Swiss multinational specialty chemical company that supplies to the building sector and motor vehicle industry, since 2019 and has been Chairman of the Board since March 2024. He has also been a member of the Board of Directors of Aliaxis SA, a manufacturer of plastic piping systems for buildings, infrastructure, and industry since 2020, and Chairman of the Board since 2022, and a member of the Board of Directors of Stahl, a leading provider of specialty coatings and treatments for flexible substrates, since May 2024, and Etex NV, a manufacturer of building materials, since 2021. Mr. Vanlancker received his MSc Chemical Engineering from the University of Ghent, Belgium.
杜邦公司(NYSE:CBT)今天宣佈,Thierry Vanlancker已於2024年7月12日當選爲該公司的董事會成員。他還被任命爲董事會審計委員會成員,任期自2024年7月12日起。在退休之前,Vanlancker先生曾擔任多國塗料和塗層公司AkzoNobel NV的首席執行官和董事,任期爲2017年至2022年。在加入AkzoNobel之前,Vanlancker先生曾擔任全球性能化學品供應商The Chemours Company的氟化產品和EMEA地區總裁,任職於2015年至2016年。在1988年至2015年期間,他在化學公司杜邦擔任各種職務。自2019年起,Vanlancker先生一直擔任瑞士跨國特種化學品公司SIKA AG的董事會成員,該公司向建築業和汽車工業提供供應,並自2024年3月起擔任董事長。自2020年以來,他還是建築管道系統製造商Aliaxis SA的董事會成員,並自2022年起擔任董事長,自2024年5月以來,他還是著名的柔性基板特種塗料和處理劑供應商Stahl的董事會成員以及建築材料製造商Etex NV的董事會成員。Vanlancker先生獲得了比利時根特大學的MSc化學工程學位。
Michael M. Morrow, Non-Executive Chair of Cabot's Board of Directors, said, "We are very pleased to welcome Thierry to our Board. Having held various management positions in the chemical sector for more than 30 years, Thierry brings with him extensive global and industrial experience. He possesses in-depth knowledge of strategy, product development, sales, and marketing with specific know-how in chemicals markets and distribution. His strong expertise in the management of international companies, management of differentiated channels to market and in-depth experience with sustainability strategy will further enhance the Board's depth of expertise and capabilities that are necessary to oversee the Company's Creating for Tomorrow strategy."
卡博特的非執行董事主席邁克爾·莫羅(Michael M. Morrow)表示:“我們非常高興歡迎蒂埃里加入我們的董事會。蒂埃裏在化學板塊擔任多個管理職位超過30年,帶來了豐富的全球和工業經驗。他擁有深入的策略、產品開發、銷售和營銷知識,特別是在化學品市場和銷售渠道的專業知識。他在國際公司管理、不同渠道市場營銷和可持續性策略方面的強大專業知識將進一步增強董事會的專業知識和能力,這是必要的來監督公司的創建未來策略。”
"I am honored to join the Cabot Board of Directors. Cabot has innovative technologies and many exciting opportunities for growth. I look forward to helping Cabot capitalize on those opportunities and further advance their strategy and objectives in the years to come," said Mr. Vanlancker.
“我很榮幸能加入卡博特的董事會。卡博特擁有創新技術和許多令人興奮的增長機會。我期待着幫助卡博特抓住這些機會,在未來數年內推進他們的戰略和目標,”Vanlancker先生說。
About Cabot Corporation
關於Cabot Corporation Cabot Corporation(NYSE:CBT)是一家總部位於馬薩諸塞州波士頓的全球性特種化學品和高性能材料公司。該公司是增強碳、特殊碳、電池材料、工程彈性體複合材料、噴墨顏料、母料和導電化合物、煙霧金屬氧化物和氣凝膠的領先供應商。有關Cabot的更多信息,請訪問公司的網站cabotcorp.com。公司鼓勵投資者和潛在投資者定期查閱Cabot網站。
Cabot Corporation (NYSE: CBT) is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company is a leading provider of reinforcing carbons, specialty carbons, battery materials, engineered elastomer composites, inkjet colorants, masterbatches and conductive compounds, fumed metal oxides and aerogel. For more information on Cabot, please visit the company's website at cabotcorp.com. The Company encourages investors and potential investors to consult the Cabot website regularly.
前瞻性聲明-本發佈含有前瞻性聲明。所有關於未來預期或預測的聲明,包括關於公司戰略和增長機會的聲明,都是前瞻性聲明。這些聲明不能保證未來的業績,並且受到風險、不確定性、潛在不準確的假設和其他一些超出我們控制範圍和難以預測的因素的影響,其中一些風險、不確定性、不準確的假設和其他因素可能導致我們實際結果與過去結果以及與前瞻性聲明的表達或暗示的結果都不同。影響我們的出業績的重要因素包括但不限於行業產能利用率和其他特種化學品公司的競爭;針對我們業務的安全、衛生和環境要求和相關限制;與氣候變化有關的監管和財務風險;能源和原材料價格和供應的波動,包括針對烏克蘭的俄羅斯入侵和美中貿易關係;客戶關係的重大不利變化或客戶未能履行協議義務;無法實現新產品、應用和技術的發展帶來的增長預期;無法實現收購、聯盟或合資企業帶來的好處,或實現我們的組合管理目標;出人意料的現場開發項目的延遲或成本增加;負向或不確定的全球或地區經濟形勢和市場機會,包括貿易關係、全球衛生事務或地緣政治衝突;訴訟或法律訴訟;利率、稅率、貨幣匯率控制和外匯匯率波動以及最近發生在阿根廷的貨幣運動的準確性等方面的準確性我們用來建立呼吸器索賠責任估計的假設。這些因素在我們向證券交易委員會(“SEC”)提交的報告中得到了更充分的討論,特別是在我們的年度報告中,2013年10月結束的財年10-K中,這些報告在www.sec.gov上提交給了SEC。我們認爲,除非情況發生變化,否則無需對任何前瞻性聲明進行修訂,除非證券和其他適用法律要求我們這樣做。
Forward-Looking Statements – This release contains forward-looking statements. All statements that address expectations or projections about the future, including with respect to the Company's strategy and opportunities for growth, are forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties, potentially inaccurate assumptions, and other factors, some of which are beyond our control and difficult to predict. If known or unknown risks materialize, or should underlying assumptions prove inaccurate, our actual results could differ materially from past results and from those expressed or implied by forward-looking statements. Important factors that could cause our results to differ materially from those expressed or implied in the forward-looking statements include, but are not limited to, industry capacity utilization and competition from other specialty chemical companies; safety, health and environmental requirements and related constraints imposed on our business; regulatory and financial risks related to climate change developments; volatility in the price and availability of energy and raw materials, including with respect to the Russian invasion of Ukraine and the U.S.-China trade relationship; a significant adverse change in a customer relationship or the failure of a customer to perform its obligations under agreements with us; failure to achieve growth expectations from new products, applications and technology developments; failure to realize benefits from acquisitions, alliances, or joint ventures or achieve our portfolio management objectives; unanticipated delays in, or increased cost of site development projects; negative or uncertain worldwide or regional economic conditions and market opportunities, including from trade relations, global health matters or geo-political conflicts; litigation or legal proceedings; interest rates, tax rates, currency exchange controls and fluctuations in foreign currency rates such as the recent currency movements in Argentina; and the accuracy of the assumptions we used in establishing reserves for our share of liability for respirator claims. These factors are discussed more fully in the reports we file with the Securities and Exchange Commission ("SEC"), particularly under the heading "Risk Factors" in our annual report on Form 10-K for our fiscal year ended September 30, 2023, which are filed with the SEC at www.sec.gov. We assume no obligation to provide revisions to any forward-looking statements should circumstances change, except as otherwise required by securities and other applicable laws.
前瞻性聲明-本發佈包含前瞻性聲明。涉及未來的所有關於我們戰略和增長機會等預期或預測的陳述都屬於前瞻性聲明。這些陳述不是對未來表現的保證,而是受到各種風險、不確定性、可能不準確的假設和其他因素的約束,其中一些因素超出了我們的掌控,並且難以預測。如果已知或未知的風險材料化,或者底層假設被證明不準確,我們的實際結果可能會與過去的結果以及前瞻性聲明所表達或暗示的結果有所不同。可能導致我們的結果與前瞻性聲明所表達或暗示的結果不同的重要因素包括,但不限於,行業產能利用率及其他專業化化學公司的競爭;我們業務所面臨的安全、健康和環境要求及相關限制;因氣候變化發展帶來的監管和財務風險;與俄羅斯入侵烏克蘭和中美貿易關係有關的能源和原材料價格和供應的波動;客戶關係顯著不利變化或客戶未能履行與我們達成的協議的風險;未能實現從新產品、應用和技術發展中的增長期望;未能從收購、聯盟或合資企業中實現利益或實現我們的組合管理目標;工地開發項目出現意外延遲或成本增加;全球或地區經濟條件和市場機遇不利或不確定,包括貿易關係、全球衛生問題或地緣政治衝突;訴訟或法律程序;利率、稅率、貨幣兌換控制和外匯匯率波動,如阿根廷最近的貨幣波動;以及我們用來建立對呼吸器索賠責任的股權負債準備預測的準確性。這些因素在我們向證券交易委員會("SEC")提交的報告中得到更全面地討論,特別是在我們截至2023年9月30日的財年年報的"風險因素"一節中,該報告在SEC網站(www.sec.gov)上提交。我們不承擔修改任何前瞻性聲明的義務,除非情況發生變化,否則應遵守證券和其他適用法律的規定。
View source version on businesswire.com:
請查看商業線(businesswire.com)的源版本。
Investor Contact:
Steve Delahunt
(617) 342-6255
投資者聯繫人:
史蒂夫·德拉亨特
(617) 342-6255
Source: Cabot Corporation
資訊來源:卡博特公司